Teva Recalls APRI Oral Contraceptive Tablets Due to Impurity Test Failures
Teva Pharmaceuticals is recalling 1,104 packs of APRI oral contraceptives because impurity test results were out of specification.
- Product
- APRI — APRI (DESOGESTREL AND ETHINYL ESTRADIOL)
- Category
- Drug
- Distribution
- Distributed nationwide